Human KRT10(Keratin 10) ELISA Kit
To Order Contact us below: [email protected]
 ELISA Kit) Human Keratin 10 (KRT10) ELISA Kit |
|
RD-KRT10-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 600 |
Human Keratin 10 (KRT10) ELISA Kit |
|
RD-KRT10-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 830.4 |
Human Keratin 10 (KRT10) ELISA Kit |
|
20-abx152104 |
Abbexa |
-
EUR 8534.40
-
EUR 4550.40
-
EUR 1054.80
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
Human Keratin 10 (KRT10) ELISA Kit |
|
abx251545-96tests |
Abbexa |
96 tests |
EUR 848.4 |
|
|
Human Keratin 10 (KRT10) ELISA Kit |
|
abx574505-96tests |
Abbexa |
96 tests |
EUR 848.4 |
|
|
Human Keratin 10 (KRT10) ELISA Kit |
|
SEB691Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 5402.92 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 10 (KRT10) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Keratin 10 (KRT10) ELISA Kit |
|
SEB691Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 550.13 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 10 (KRT10) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Keratin 10 (KRT10) ELISA Kit |
|
SEB691Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 734.46 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 10 (KRT10) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Keratin 10 (KRT10) ELISA Kit |
|
SEB691Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 2945.08 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 10 (KRT10) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Keratin 10 (KRT10) ELISA Kit |
|
4-SEB691Hu |
Cloud-Clone |
-
EUR 5463.60
-
EUR 2886.00
-
EUR 735.60
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Keratin 10 (KRT10) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species. |
) Human Keratin 10 ELISA Kit (KRT10) |
|
RK01738 |
Abclonal |
96 Tests |
EUR 625.2 |
 ELISA Kit) Cow Keratin 10 (KRT10) ELISA Kit |
|
abx519988-96tests |
Abbexa |
96 tests |
EUR 1093.2 |
|
|
 ELISA Kit) Dog Keratin 10 (KRT10) ELISA Kit |
|
abx519989-96tests |
Abbexa |
96 tests |
EUR 1093.2 |
|
|
 ELISA Kit) Mouse Keratin 10 (KRT10) ELISA Kit |
|
abx519991-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
|
 ELISA Kit) Rat Keratin 10 (KRT10) ELISA Kit |
|
abx519992-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
|
) ELISA kit for Human KRT10 (Keratin 10) |
|
ELK2149 |
ELK Biotech |
1 plate of 96 wells |
EUR 518.4 |
|
|
|
Description: A sandwich ELISA kit for detection of Keratin 10 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
 Antibody) Keratin 10 (KRT10) Antibody |
|
20-abx100807 |
Abbexa |
-
EUR 493.20
-
EUR 159.60
-
EUR 1378.80
-
EUR 678.00
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Keratin 10 (KRT10) Antibody |
|
20-abx100808 |
Abbexa |
-
EUR 526.80
-
EUR 159.60
-
EUR 1496.40
-
EUR 710.40
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Keratin 10 (KRT10) Antibody |
|
20-abx123052 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Keratin 10 (KRT10) Antibody |
|
20-abx113334 |
Abbexa |
|
|
|
|
Keratin 10 (KRT10) Antibody |
|
20-abx013128 |
Abbexa |
-
EUR 376.80
-
EUR 117.60
-
EUR 477.60
-
EUR 594.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
|
Keratin 10 (KRT10) Antibody |
|
abx032944-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
|
Keratin 10 (KRT10) Antibody |
|
abx032944-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
|
Keratin 10 (KRT10) Antibody |
|
abx032945-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
|
Keratin 10 (KRT10) Antibody |
|
abx032945-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
|
Keratin 10 (KRT10) Antibody |
|
20-abx210411 |
Abbexa |
|
|
|
|
Keratin 10 (KRT10) Antibody |
|
abx332811-100ul |
Abbexa |
100 ul |
EUR 510 |
|
|
Keratin 10 (KRT10) Antibody |
|
20-abx329415 |
Abbexa |
|
|
|
|
Keratin 10 (KRT10) Antibody |
|
abx224350-100ug |
Abbexa |
100 ug |
EUR 493.2 |
|
|
Keratin 10 (KRT10) Antibody |
|
abx224458-100ug |
Abbexa |
100 ug |
EUR 493.2 |
|
|
Keratin 10 (KRT10) Antibody |
|
20-abx242429 |
Abbexa |
|
|
|
|
Keratin 10 (KRT10) Antibody |
|
abx234648-100ug |
Abbexa |
100 ug |
EUR 610.8 |
|
|
Keratin 10 (KRT10) Antibody |
|
20-abx211361 |
Abbexa |
|
|
|
|
Keratin 10 (KRT10) Antibody |
|
20-abx173242 |
Abbexa |
|
|
|
|
) Recombinant Keratin 10 (KRT10) |
|
4-RPB691Hu01 |
Cloud-Clone |
-
EUR 642.55
-
EUR 295.20
-
EUR 2079.55
-
EUR 773.18
-
EUR 1426.37
-
EUR 505.20
-
EUR 5018.88
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Human Keratin 10 expressed in: E.coli |
Recombinant Keratin 10 (KRT10) |
|
4-RPB691Ra01 |
Cloud-Clone |
-
EUR 614.59
-
EUR 288.00
-
EUR 1974.72
-
EUR 738.24
-
EUR 1356.48
-
EUR 487.20
-
EUR 4756.80
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Rat Keratin 10 expressed in: E.coli |
 CLIA Kit) Human Keratin 10 (KRT10) CLIA Kit |
|
20-abx492996 |
Abbexa |
-
EUR 9567.60
-
EUR 5095.20
-
EUR 1177.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
 Protein) Human Keratin 10 (KRT10) Protein |
|
20-abx067604 |
Abbexa |
-
EUR 895.20
-
EUR 360.00
-
EUR 2798.40
-
EUR 1062.00
-
EUR 627.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Protein) Rat Keratin 10 (KRT10) Protein |
|
20-abx067605 |
Abbexa |
-
EUR 861.60
-
EUR 343.20
-
EUR 2665.20
-
EUR 1028.40
-
EUR 610.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Antibody (Biotin)) Keratin 10 (KRT10) Antibody (Biotin) |
|
20-abx273364 |
Abbexa |
-
EUR 577.20
-
EUR 292.80
-
EUR 1696.80
-
EUR 794.40
-
EUR 427.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Polyclonal Antibody (Human)) Keratin 10 (KRT10) Polyclonal Antibody (Human) |
|
4-PAB691Hu01 |
Cloud-Clone |
-
EUR 286.80
-
EUR 2869.20
-
EUR 717.60
-
EUR 358.80
-
EUR 253.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10) |
 ELISA Kit) Human KRT10(Keratin, type I cytoskeletal 10) ELISA Kit |
|
EH2203 |
FN Test |
96T |
EUR 628.92 |
|
|
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 9.375pg/ml |
 Human KRT10/ Keratin, type I cytoskeletal 10 ELISA Kit |
|
E1399Hu |
Sunlong |
1 Kit |
EUR 685.2 |
 Human Keratin, type I cytoskeletal 10, KRT10 ELISA KIT |
|
ELI-07330h |
Lifescience Market |
96 Tests |
EUR 988.8 |
ELISA Kit) Human Keratin, type I cytoskeletal 10(KRT10)ELISA Kit |
|
YLA4484HU-48T |
Shanghai YL Biotech |
48T |
EUR 435 |
Human Keratin, type I cytoskeletal 10(KRT10)ELISA Kit |
|
YLA4484HU-96T |
Shanghai YL Biotech |
96T |
EUR 562.5 |
) Human Keratin, type I cytoskeletal 10 (KRT10) |
|
1-CSB-EP012504HU |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Human Keratin, type I cytoskeletal 10(KRT10) expressed in E.coli |
) Human KeRatin, type I cytoskeletal 10 (KRT10) |
|
1-CSB-YP012504HU1 |
Cusabio |
-
EUR 516.00
-
EUR 280.80
-
EUR 1809.60
-
EUR 770.40
-
EUR 1210.80
-
EUR 349.20
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Human KeRatin, type I cytoskeletal 10(KRT10),partial expressed in Yeast |
 Polyclonal Antibody (Human), APC) Keratin 10 (KRT10) Polyclonal Antibody (Human), APC |
|
4-PAB691Hu01-APC |
Cloud-Clone |
-
EUR 399.60
-
EUR 3735.60
-
EUR 1046.40
-
EUR 507.60
-
EUR 258.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with APC. |
 Polyclonal Antibody (Human), Biotinylated) Keratin 10 (KRT10) Polyclonal Antibody (Human), Biotinylated |
|
4-PAB691Hu01-Biotin |
Cloud-Clone |
-
EUR 363.60
-
EUR 2809.20
-
EUR 836.40
-
EUR 442.80
-
EUR 259.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with Biotin. |
 Polyclonal Antibody (Human), Cy3) Keratin 10 (KRT10) Polyclonal Antibody (Human), Cy3 |
|
4-PAB691Hu01-Cy3 |
Cloud-Clone |
-
EUR 483.60
-
EUR 4930.80
-
EUR 1345.20
-
EUR 627.60
-
EUR 294.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with Cy3. |
 Polyclonal Antibody (Human), FITC) Keratin 10 (KRT10) Polyclonal Antibody (Human), FITC |
|
4-PAB691Hu01-FITC |
Cloud-Clone |
-
EUR 344.40
-
EUR 3012.00
-
EUR 860.40
-
EUR 430.80
-
EUR 230.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with FITC. |
 Polyclonal Antibody (Human), HRP) Keratin 10 (KRT10) Polyclonal Antibody (Human), HRP |
|
4-PAB691Hu01-HRP |
Cloud-Clone |
-
EUR 366.00
-
EUR 3256.80
-
EUR 926.40
-
EUR 459.60
-
EUR 243.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with HRP. |
 Polyclonal Antibody (Human), PE) Keratin 10 (KRT10) Polyclonal Antibody (Human), PE |
|
4-PAB691Hu01-PE |
Cloud-Clone |
-
EUR 344.40
-
EUR 3012.00
-
EUR 860.40
-
EUR 430.80
-
EUR 230.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with PE. |
 Polyclonal Antibody (Rat)) Keratin 10 (KRT10) Polyclonal Antibody (Rat) |
|
4-PAB691Ra01 |
Cloud-Clone |
-
EUR 301.20
-
EUR 3106.80
-
EUR 771.60
-
EUR 380.40
-
EUR 259.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10) |
) ELISA kit for Human Keratin, type I cytoskeletal 10 (KRT10) |
|
KTE61887-48T |
Abbkine |
48T |
EUR 398.4 |
|
|
|
Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 10 (KRT10) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Keratin, type I cytoskeletal 10 (KRT10) |
|
KTE61887-5platesof96wells |
Abbkine |
5 plates of 96 wells |
EUR 2538 |
|
|
|
Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 10 (KRT10) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Keratin, type I cytoskeletal 10 (KRT10) |
|
KTE61887-96T |
Abbkine |
96T |
EUR 646.8 |
|
|
|
Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 10 (KRT10) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
) ELISA kit for Human KRT10 (Keratin, Type I Cytoskeletal 10) |
|
E-EL-H2118 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 640.8 |
|
|
|
Description: A sandwich ELISA kit for quantitative measurement of Human KRT10 (Keratin, Type I Cytoskeletal 10) in samples from Serum, Plasma, Cell supernatant |
 Dog KRT10/ Keratin, type I cytoskeletal 10 ELISA Kit |
|
E0066Do |
Sunlong |
1 Kit |
EUR 860.4 |
 Mouse Keratin, type I cytoskeletal 10, Krt10 ELISA KIT |
|
ELI-07327m |
Lifescience Market |
96 Tests |
EUR 1038 |
 Bovine Keratin, type I cytoskeletal 10, KRT10 ELISA KIT |
|
ELI-07328b |
Lifescience Market |
96 Tests |
EUR 1113.6 |
ELISA Kit) Rat Keratin, type I cytoskeletal 10(KRT10)ELISA Kit |
|
YLA1722RA-48T |
Shanghai YL Biotech |
48T |
EUR 465 |
Rat Keratin, type I cytoskeletal 10(KRT10)ELISA Kit |
|
YLA1722RA-96T |
Shanghai YL Biotech |
96T |
EUR 600 |
 CLIA Kit) Human Keratin, Type I Cytoskeletal 10 (KRT10) CLIA Kit |
|
abx195422-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 Keratin 10 antibody |
|
10-2541 |
Fitzgerald |
250 ug |
EUR 590.4 |
|
Description: Mouse monoclonal Keratin 10 antibody |
 Polyclonal Antibody (Human), APC-Cy7) Keratin 10 (KRT10) Polyclonal Antibody (Human), APC-Cy7 |
|
4-PAB691Hu01-APC-Cy7 |
Cloud-Clone |
-
EUR 656.40
-
EUR 7327.20
-
EUR 1948.80
-
EUR 872.40
-
EUR 372.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with APC-Cy7. |
 Antibody) Keratin, Type I Cytoskeletal 10 (KRT10) Antibody |
|
20-abx109953 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Polyclonal Antibody (Rat), APC) Keratin 10 (KRT10) Polyclonal Antibody (Rat), APC |
|
4-PAB691Ra01-APC |
Cloud-Clone |
-
EUR 422.40
-
EUR 4059.60
-
EUR 1126.80
-
EUR 540.00
-
EUR 267.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with APC. |
 Polyclonal Antibody (Rat), Biotinylated) Keratin 10 (KRT10) Polyclonal Antibody (Rat), Biotinylated |
|
4-PAB691Ra01-Biotin |
Cloud-Clone |
-
EUR 379.20
-
EUR 3046.80
-
EUR 896.40
-
EUR 465.60
-
EUR 265.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with Biotin. |
 Polyclonal Antibody (Rat), Cy3) Keratin 10 (KRT10) Polyclonal Antibody (Rat), Cy3 |
|
4-PAB691Ra01-Cy3 |
Cloud-Clone |
-
EUR 513.60
-
EUR 5362.80
-
EUR 1453.20
-
EUR 670.80
-
EUR 306.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with Cy3. |
 Polyclonal Antibody (Rat), FITC) Keratin 10 (KRT10) Polyclonal Antibody (Rat), FITC |
|
4-PAB691Ra01-FITC |
Cloud-Clone |
-
EUR 362.40
-
EUR 3271.20
-
EUR 925.20
-
EUR 456.00
-
EUR 237.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with FITC. |
 Polyclonal Antibody (Rat), HRP) Keratin 10 (KRT10) Polyclonal Antibody (Rat), HRP |
|
4-PAB691Ra01-HRP |
Cloud-Clone |
-
EUR 386.40
-
EUR 3537.60
-
EUR 996.00
-
EUR 488.40
-
EUR 252.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with HRP. |
 Polyclonal Antibody (Rat), PE) Keratin 10 (KRT10) Polyclonal Antibody (Rat), PE |
|
4-PAB691Ra01-PE |
Cloud-Clone |
-
EUR 362.40
-
EUR 3271.20
-
EUR 925.20
-
EUR 456.00
-
EUR 237.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with PE. |
) CLIA kit for Human KRT10 (Keratin, Type I Cytoskeletal 10) |
|
E-CL-H1268 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 700.8 |
|
|
|
Description: A sandwich CLIA kit for quantitative measurement of Human KRT10 (Keratin, Type I Cytoskeletal 10) in samples from Serum, Plasma, Cell supernatant |
 Polyclonal Antibody (Rat), APC-Cy7) Keratin 10 (KRT10) Polyclonal Antibody (Rat), APC-Cy7 |
|
4-PAB691Ra01-APC-Cy7 |
Cloud-Clone |
-
EUR 702.00
-
EUR 7975.20
-
EUR 2110.80
-
EUR 937.20
-
EUR 391.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with APC-Cy7. |
 Keratin 10 Cell ELISA Kit |
|
abx595336-96tests |
Abbexa |
96 tests |
EUR 764.4 |
|
|
 Human Keratin- associated protein 10- 10, KRTAP10-10 ELISA KIT |
|
ELI-19292h |
Lifescience Market |
96 Tests |
EUR 988.8 |
 KRT10 Antibody / Cytokeratin 10 |
|
V9057-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V9057-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V9057IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V9057SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V2666-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V2666-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: This mAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V2666IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V2666SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3181-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3181-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3181IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3181SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3188-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
KRT10 Antibody / Cytokeratin 10 |
|
V3188-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
KRT10 Antibody / Cytokeratin 10 |
|
V3188SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
KRT10 Antibody / Cytokeratin 10 |
|
V3310-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3310-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3310SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3602-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3602-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3602IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3602SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3603-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (KRT10). KRT10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of KRT10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, KRT10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), KRT10 is detected very frequently. Expression is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3603-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (KRT10). KRT10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of KRT10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, KRT10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), KRT10 is detected very frequently. Expression is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3603IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (KRT10). KRT10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of KRT10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, KRT10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), KRT10 is detected very frequently. Expression is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3603SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (KRT10). KRT10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of KRT10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, KRT10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), KRT10 is detected very frequently. Expression is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3632-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3632-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3632IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3632SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3633-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3633-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3633IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3633SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V3711-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Cytokeratin-10 (CK-10) or keratin-10 (K10) is a protein that in humans is encoded by the KRT10 gene. CK10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
KRT10 Antibody / Cytokeratin 10 |
|
V3711-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Cytokeratin-10 (CK-10) or keratin-10 (K10) is a protein that in humans is encoded by the KRT10 gene. CK10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
KRT10 Antibody / Cytokeratin 10 |
|
V3711IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: Cytokeratin-10 (CK-10) or keratin-10 (K10) is a protein that in humans is encoded by the KRT10 gene. CK10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
KRT10 Antibody / Cytokeratin 10 |
|
V3711SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Cytokeratin-10 (CK-10) or keratin-10 (K10) is a protein that in humans is encoded by the KRT10 gene. CK10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
KRT10 Antibody / Cytokeratin 10 |
|
V7113-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. This gene is located within a cluster of keratin family members on chromosome 17q21. Keratin 10 has been shown to interact with AKT1. [Wiki] |
KRT10 Antibody / Cytokeratin 10 |
|
V7113-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. This gene is located within a cluster of keratin family members on chromosome 17q21. Keratin 10 has been shown to interact with AKT1. [Wiki] |
KRT10 Antibody / Cytokeratin 10 |
|
V7113IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. This gene is located within a cluster of keratin family members on chromosome 17q21. Keratin 10 has been shown to interact with AKT1. [Wiki] |
KRT10 Antibody / Cytokeratin 10 |
|
V7113SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. This gene is located within a cluster of keratin family members on chromosome 17q21. Keratin 10 has been shown to interact with AKT1. [Wiki] |
KRT10 Antibody / Cytokeratin 10 |
|
V2174-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This antibody recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). cytokeratin 10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of cytokeratin 10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, cytokeratin 10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), cytokeratin 10 is detected very frequently. Expression of cytokeratin 10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V2174-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: This antibody recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). cytokeratin 10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of cytokeratin 10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, cytokeratin 10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), cytokeratin 10 is detected very frequently. Expression of cytokeratin 10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V2174IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: This antibody recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). cytokeratin 10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of cytokeratin 10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, cytokeratin 10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), cytokeratin 10 is detected very frequently. Expression of cytokeratin 10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V2174SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This antibody recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). cytokeratin 10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of cytokeratin 10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, cytokeratin 10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), cytokeratin 10 is detected very frequently. Expression of cytokeratin 10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V7915-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This MAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V7915-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: This MAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
KRT10 Antibody / Cytokeratin 10 |
|
V7915SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: This MAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
 Human Keratin- associated protein 5- 10, KRTAP5-10 ELISA KIT |
|
ELI-42734h |
Lifescience Market |
96 Tests |
EUR 988.8 |
Keratin 10 antibody |
|
70R-31259 |
Fitzgerald |
100 ug |
EUR 392.4 |
|
Description: Rabbit polyclonal Keratin 10 antibody |
 Keratin 10 Antibody |
|
33422-100ul |
SAB |
100ul |
EUR 302.4 |
Keratin 10 Antibody |
|
33422-50ul |
SAB |
50ul |
EUR 224.4 |
 Antibody) Cytokeratin 10(KRT10/844) Antibody |
|
BNC040844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF405S conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC040844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF405S conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC050844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF405M conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC050844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF405M conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNCAP0844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNCAP0844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNCB0844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), Biotin conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNCB0844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), Biotin conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNCP0844-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), PerCP conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNCR0844-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), RPE conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC940844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF594 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC940844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF594 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNCA0844-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), APC conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC810844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF680R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC810844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF680R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNUB0844-100 |
Biotium |
100uL |
EUR 250.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), Concentration: 0.2mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNUB0844-500 |
Biotium |
500uL |
EUR 549.6 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), Concentration: 0.2mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNCH0844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNCH0844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC880844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF488A conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC880844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF488A conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC680844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF568 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC680844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF568 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC470844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF647 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC470844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF647 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC400844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF640R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC400844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF640R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC430844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF543 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC430844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF543 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC550844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF555 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC550844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF555 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC610844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF660R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC610844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF660R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC800844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF680 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC800844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF680 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC700844-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF770 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNC700844-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF770 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 10(KRT10/844) Antibody |
|
BNUM0844-50 |
Biotium |
50uL |
EUR 474 |
|
Description: Primary antibody against Cytokeratin 10(KRT10/844), 1mg/mL |
Human KRT10(Keratin 10) ELISA Kit
